MedikitMEDIKIT CO.,LTD7749東証スタンダード精密機器FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥18 is left as operating profit. Revenue changed +5.4% from the prior year, operating profit -4.8%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 14.9% | 0.39× | 5.9% | 1.12× | 6.6% |
| 2023 | 13.3% | 0.41× | 5.5% | 1.13× | 6.2% |
| 2024 | 14.0% | 0.42× | 5.9% | 1.15× | 6.8% |
| 2025 | 13.4% | 0.44× | 5.8% | 1.18× | 6.9% |
| 2026 | 12.6% | 0.45× | 5.7% | 1.17× | 6.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 20,131 | 21,607 | 21,851 | 22,553 | 23,781 |
| Cost of revenue | 11,950 | 13,288 | 13,098 | 13,885 | 14,774 |
| Gross profit | 8,181 | 8,319 | 8,753 | 8,668 | 9,008 |
| SG&A | 3,758 | 4,201 | 4,075 | 4,181 | 4,736 |
| Operating income | 4,423 | 4,118 | 4,678 | 4,487 | 4,272 |
| Pretax income | 4,473 | 4,291 | 4,775 | 4,660 | 4,512 |
| Income tax | 1,480 | 1,427 | 1,706 | 1,646 | 1,506 |
| Net income attributable to owners | 2,993 | 2,865 | 3,069 | 3,014 | 3,006 |
| Operating margin | 22.0% | 19.1% | 21.4% | 19.9% | 18.0% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥18.1B | ¥17.6B | ¥19.1B | ¥17.1B | ¥18.7B |
| Total assets | ¥51.1B | ¥53.2B | ¥51B | ¥52.5B | ¥53.3B |
| Net assets | ¥45.8B | ¥47.3B | ¥44.1B | ¥45.2B | ¥46.8B |
| Share capital | ¥1.24B | ¥1.24B | ¥1.24B | ¥1.24B | ¥1.24B |
| Property, plant and equipment | ¥10.8B | ¥10.4B | ¥11.5B | ¥14.4B | ¥14.9B |
| Intangible assets excluding goodwill | ¥126.6M | ¥3.09B | ¥3.48B | ¥3.28B | ¥2.95B |
| Goodwill | — | ¥1.94B | ¥2.34B | ¥2.12B | ¥1.9B |
| Investment securities | ¥927.7M | ¥881.9M | ¥962M | ¥778.8M | ¥1.3B |
| Current assets | ¥38.5B | ¥38.2B | ¥34.5B | ¥33.2B | ¥33.2B |
| Current liabilities | ¥4.41B | ¥4.67B | ¥5.72B | ¥6.16B | ¥5.31B |
| Trade payables | ¥2.58B | ¥2.55B | ¥3.18B | ¥3.47B | ¥925.2M |
| Total liabilities | ¥5.29B | ¥5.89B | ¥6.87B | ¥7.31B | ¥6.49B |
| Equity attributable to owners of parent | ¥45.5B | ¥46.9B | ¥43.5B | ¥44.4B | ¥45.7B |
| Retained earnings | ¥37.2B | ¥38.5B | ¥39.8B | ¥37.3B | ¥39B |
| Treasury stock | -¥3.26B | -¥3.24B | -¥6.05B | -¥2.55B | -¥2.93B |
EDINET (FSA Japan)
有価証券報告書－第43期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第42期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第41期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第40期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第39期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第38期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 50 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.